Inogen Inc(INGN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,444 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
INGN Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Inogen Inc (INGN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INGN at 31.9/100 on a 32-signal composite quality model, placing it at rank #2,444 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (18.8) and free cash flow (24.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 37.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Inogen Inc reports quarterly revenue of $95.1M, net income of $-3.9M, an operating margin of -5.4%. Top institutional holders of INGN by reported 13-F value include BlackRock, ARMISTICE CAPITAL, ACADIAN ASSET MANAGEMENT, based on the most recent SEC filings. INGN trades on the Nasdaq exchange and files with the SEC under CIK 1294133. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Inogen Inc directly from SEC EDGAR. Inogen Inc's 13F Pro composite quality score has ranged between 19 and 44 since 2021, currently 31.9 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$95.1M
Net Income
Q2 2026
$-3.9M
Free Cash Flow
Q2 2026
$2.2M
Operating Margin
Q2 2026
-5.4%
ROIC
Q2 2026
-11.7%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+3.9% YoYNet Income
+36.6% YoYOperating Income
+29.0% YoYEPS (Diluted)
+43.4% YoYTotal Assets
+0.8% YoYOp. Cash Flow
-289.7% YoYFree Cash Flow
-637.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $348.7M +3.9% | $335.7M +6.4% | $315.7M -16.3% | $377.2M +5.4% | $358.0M +16.1% | $308.5M |
| Net Income | $-22.7M +36.6% | $-35.9M +65.0% | $-102.4M -22.3% | $-83.8M -1222.8% | $-6.3M -8.6% | $-5.8M |
| Operating Income | $-30.2M +29.0% | $-42.5M +61.1% | $-109.4M -28.3% | $-85.2M -1022.5% | $9.2M +176.8% | $-12.0M |
| EPS (Diluted) | $-0.86 +43.4% | $-1.52 +65.6% | $-4.42 -20.4% | $-3.67 -1210.7% | $-0.28 -3.7% | $-0.27 |
| Total Assets | $298.6M +0.8% | $296.2M -9.2% | $326.2M -19.5% | $405.0M -17.3% | $489.5M +6.0% | $461.9M |
| Operating Cash Flow | $-11.2M -289.7% | $5.9M +282.9% | $-3.2M +91.4% | $-37.5M -258.8% | $23.6M -36.1% | $37.0M |
| Free Cash Flow | $-13.7M -637.9% | $2.6M +130.2% | $-8.5M +79.3% | $-40.9M -325.2% | $18.2M -44.4% | $32.6M |
Get alerted when INGN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Inogen Inc including:
Top Institutional Holders of INGN
BlackRock, Inc.
$11.3M1,748,986 shARMISTICE CAPITAL, LLC
$7.1M1,096,000 shACADIAN ASSET MANAGEMENT LLC
$7.1M1,096,879 shVANGUARD CAPITAL MANAGEMENT LLC
$6.7M1,038,316 shAMERIPRISE FINANCIAL INC
$6.3M983,028 shAQR CAPITAL MANAGEMENT LLC
$6.0M937,334 shDAFNA Capital Management LLC
$5.5M845,179 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$4.8M743,252 shMORGAN STANLEY
$4.2M646,276 shGEODE CAPITAL MANAGEMENT, LLC
$4.1M641,521 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $11.3M | 1,748,986 |
| ARMISTICE CAPITAL, LLC | $7.1M | 1,096,000 |
| ACADIAN ASSET MANAGEMENT LLC | $7.1M | 1,096,879 |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.7M | 1,038,316 |
| AMERIPRISE FINANCIAL INC | $6.3M | 983,028 |
| AQR CAPITAL MANAGEMENT LLC | $6.0M | 937,334 |
| DAFNA Capital Management LLC | $5.5M | 845,179 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4.8M | 743,252 |
| MORGAN STANLEY | $4.2M | 646,276 |
| GEODE CAPITAL MANAGEMENT, LLC | $4.1M | 641,521 |
Companies Similar to INGN
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Orthofix Medical Inc.
Vanda Pharmaceuticals Inc.
ANGIODYNAMICS INC
DocGo Inc.
ORASURE TECHNOLOGIES INC
Organogenesis Holdings Inc.
NeuroPace Inc
TANDEM DIABETES CARE INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put INGN on your watchlist
Track score changes the day Inogen Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INGN a good stock to buy?
13F Pro's AI-powered analysis of Inogen Inc (INGN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INGN are available on the INGN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. INGN is classified as a small company.
Which hedge funds own INGN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INGN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Inogen Inc's investment landscape.